Johan Kurnianda

794 total citations
47 papers, 314 citations indexed

About

Johan Kurnianda is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Johan Kurnianda has authored 47 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 8 papers in Surgery and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Johan Kurnianda's work include Head and Neck Cancer Studies (5 papers), Colorectal Cancer Screening and Detection (4 papers) and Public Health and Nutrition (4 papers). Johan Kurnianda is often cited by papers focused on Head and Neck Cancer Studies (5 papers), Colorectal Cancer Screening and Detection (4 papers) and Public Health and Nutrition (4 papers). Johan Kurnianda collaborates with scholars based in Indonesia, United Kingdom and Netherlands. Johan Kurnianda's co-authors include Susanna Hilda Hutajulu, Jaap M. Middeldorp, Bing Tan, Mardiah Suci Hardianti, Matthew Allsop, Tony Mok, Valorie F. Chan, Nagahiro Saijo, James Chih‐Hsin Yang and Rose McCormack and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Johan Kurnianda

42 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johan Kurnianda Indonesia 10 176 86 63 57 53 47 314
Emma Chen Sasse Brazil 8 129 0.7× 128 1.5× 52 0.8× 58 1.0× 23 0.4× 19 294
Taher Abu Hejleh United States 11 254 1.4× 158 1.8× 23 0.4× 121 2.1× 67 1.3× 45 445
Carmela Caballero Belgium 10 164 0.9× 140 1.6× 39 0.6× 57 1.0× 84 1.6× 33 357
Gary X. Wang United States 10 236 1.3× 223 2.6× 37 0.6× 55 1.0× 45 0.8× 21 429
Sujay Srinivas India 9 122 0.7× 80 0.9× 26 0.4× 27 0.5× 20 0.4× 36 251
Gregory Rosenblatt United States 9 73 0.4× 97 1.1× 105 1.7× 56 1.0× 26 0.5× 25 311
Salvatore De Marco Italy 11 139 0.8× 70 0.8× 16 0.3× 32 0.6× 29 0.5× 25 352
Lea Choung Wong Singapore 10 140 0.8× 192 2.2× 162 2.6× 27 0.5× 49 0.9× 15 422
Sanders Chang United States 11 114 0.6× 74 0.9× 21 0.3× 138 2.4× 89 1.7× 25 417
Ratna Paul Finland 9 50 0.3× 58 0.7× 42 0.7× 34 0.6× 48 0.9× 26 330

Countries citing papers authored by Johan Kurnianda

Since Specialization
Citations

This map shows the geographic impact of Johan Kurnianda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Kurnianda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Kurnianda more than expected).

Fields of papers citing papers by Johan Kurnianda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Kurnianda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Kurnianda. The network helps show where Johan Kurnianda may publish in the future.

Co-authorship network of co-authors of Johan Kurnianda

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Kurnianda. A scholar is included among the top collaborators of Johan Kurnianda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Kurnianda. Johan Kurnianda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
4.
Hutajulu, Susanna Hilda, et al.. (2024). Clinicopathological Factors and Interleukin-6 Levels Associated With Low Relative Dose Intensity in Women With Breast Cancer Receiving First-Line Chemotherapy. World Journal of Oncology. 15(6). 942–949. 1 indexed citations
5.
Hutajulu, Susanna Hilda, et al.. (2024). Patient-reported outcomes and symptom clusters pattern of chemotherapy-induced toxicity in patients with early breast cancer. PLoS ONE. 19(2). e0298928–e0298928. 4 indexed citations
7.
Hutajulu, Susanna Hilda, et al.. (2024). Predictive Factors of Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer: A Decision Tree Model Approach. JCO Global Oncology. 10(10). e2400160–e2400160. 5 indexed citations
9.
Hutajulu, Susanna Hilda, Johan Kurnianda, Mardiah Suci Hardianti, et al.. (2023). Prognostic Value of Vimentin in Triple Negative Breast Cancer Patients Depends on Chemotherapy Regimen and p53 Mutant Expression. Breast Cancer Targets and Therapy. Volume 15. 515–524. 1 indexed citations
10.
Hutajulu, Susanna Hilda, et al.. (2023). Sexual Dysfunction Following Breast Cancer Chemotherapy: A Cross-Sectional Study in Yogyakarta, Indonesia. Cureus. 15(7). e41744–e41744. 4 indexed citations
11.
Hutajulu, Susanna Hilda, et al.. (2023). The occurrence and risk factors of chemotherapy-induced neutropenia in patients with breast cancer not receiving primary G-CSF prophylaxis. ecancermedicalscience. 17. 1618–1618. 4 indexed citations
12.
Hutajulu, Susanna Hilda, Yayi Suryo Prabandari, Bagas Suryo Bintoro, et al.. (2022). Delays in the presentation and diagnosis of women with breast cancer in Yogyakarta, Indonesia: A retrospective observational study. PLoS ONE. 17(1). e0262468–e0262468. 31 indexed citations
13.
Sulistyoningrum, Dian Caturini, et al.. (2022). Vitamin D status in breast cancer cases following chemotherapy: A pre and post observational study in a tertiary hospital in Yogyakarta, Indonesia. PLoS ONE. 17(6). e0270507–e0270507. 5 indexed citations
14.
Hutajulu, Susanna Hilda, et al.. (2020). 346P Occurence and risk factors of chemotherapy-induced neutropenia in patients with breast cancer: A hospital-based assessment in Indonesia. Annals of Oncology. 31. S1375–S1375. 1 indexed citations
15.
Hutajulu, Susanna Hilda, et al.. (2019). Effects of oxaliplatin-containing adjuvant chemotherapy on short-term survival of patients with colon cancer in Dr. Sardjito Hospital, Yogyakarta, Indonesia. Journal of Gastrointestinal Oncology. 10(2). 226–234. 4 indexed citations
16.
Hutajulu, Susanna Hilda, et al.. (2018). Correlation between vascular endothelial growth factor-A expression and tumor location and invasion in patients with colorectal cancer. Journal of Gastrointestinal Oncology. 9(6). 1099–1108. 12 indexed citations
17.
Hutajulu, Susanna Hilda, et al.. (2017). The impact of national health insurance of Indonesia on delay in diagnosis, treatment and survival of nasopharyngeal carcinoma patients. Annals of Oncology. 28. x105–x105. 1 indexed citations
18.
Hutajulu, Susanna Hilda, Johan Kurnianda, Bing Tan, & Jaap M. Middeldorp. (2014). Therapeutic implications of Epstein–Barr virus infection for the treatment of nasopharyngeal carcinoma. Therapeutics and Clinical Risk Management. 10. 721–721. 42 indexed citations
19.
Wildeman, Maarten A., Renske Fles, Andrew Vincent, et al.. (2013). Primary Treatment Results of Nasopharyngeal Carcinoma (NPC) in Yogyakarta, Indonesia. PLoS ONE. 8(5). e63706–e63706. 35 indexed citations
20.
Kurnianda, Johan, et al.. (2011). Concentration of serum HER-2/neu as a prognostic factor in locally advanced breast cancer (LABC) and metastatic breast cancer (MBC).. PubMed. 43(1). 23–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026